User:NauseaNoor
Editor·7,238 edits·since 2024/12
NauseaNoor is an editor on PeptidePedia Wiki, editing since 2024 / 12.
This editor works mainly on adverse effects and clinical safety. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
7,238Total edits
18Logged here
17Articles touched
2024/12Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is adverse effects and clinical safety.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| International nonproprietary name | 1 | 31 | 3% |
| Medutest | 1 | 37 | 3% |
| Trial data comparison | 1 | 35 | 3% |
| Reverse-phase HPLC | 1 | 37 | 3% |
| Peptide synthesis | 1 | 39 | 3% |
| SURPASS trial programme | 1 | 35 | 3% |
| Hypoglycaemia | 1 | 26 | 4% |
| Prescribing information | 1 | 28 | 4% |
| Enteroendocrine L cell | 1 | 30 | 3% |
| Weight regain after discontinuation | 1 | 33 | 3% |
| Reconstitution calculator | 1 | 31 | 3% |
| Injection site rotation | 1 | 26 | 4% |
| Liquid chromatography-mass spectrometry | 1 | 28 | 4% |
| Contraindications of incretin therapy | 1 | 28 | 4% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.